BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Daiichi Pharmaceutical (JPN) Enters Funded Research Agreement With Cyntellect, Inc.


10/19/2005 5:13:10 PM

SAN DIEGO, March 30 /PRNewswire/ -- Cyntellect, Inc., a privately-held biotechnology company, today announced the company has entered into a research agreement with Daiichi Pharmaceutical Co., Ltd. ("Daiichi") to utilize Cyntellect's high-throughput cell imaging and laser-based cell manipulation technology, LEAP(TM), for novel drug discovery.

Under the terms of the collaboration, Cyntellect will design, configure and run LEAP cell-based assays against a compound collection provided by Daiichi. Specific financial terms were not disclosed.

"We are pleased to establish a formal research relationship with Daiichi, one of Japan's leading pharmaceutical companies," stated Dr. Fred Koller, President and CTO. "Daiichi's commitment to Cyntellect and LEAP represents another important validation of our technology and highlights the unique value proposition presented by combining imaging and cell manipulation in the process of discovering new therapeutics."

About Daiichi Pharmaceuticals, Co. Ltd.

Daiichi Pharmaceutical Co., Ltd., has been a leader in the Japanese pharmaceutical industry for nearly a century. Established in 1918, the Company has grown as a research and development (R&D) based organization, ensuring its leading position as a developer of advanced pharmaceutical products and health care related chemicals for nearly 90 years. Daiichi Pharmaceutical continues to contribute to the pharmaceutical industry by creating products that improve health and promote longer and happier lives.

About Cyntellect

Cyntellect, Inc. is a biotechnology company committed to revolutionizing the use of living cells in life sciences research and cellular therapy. The Company combines expertise in high-speed cell imaging and laser-based manipulation to develop products that enable novel cell imaging, purification, and transfection capabilities to enhance the productivity of laboratory research, recombinant protein production, high-content cellular assays, functional genomics and proteomics, and cell purification, including processing of cells for therapeutic transplantation. For additional information please visit the Company's web site at http://www.cyntellect.com/.

Cyntellect, Inc.

CONTACT: Jim Linton, Ph.D., Chief Business Officer of Cyntellect, Inc.,+1-858-450-7060, jlinton@cyntellect.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES